Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
Clinical trial NCT00003897 · COMPLETED
Trial details
- NCT number
- NCT00003897
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-05-01
- Primary completion
- 2001-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.